SCHEMBL19976855

SCHEMBL19976855

C/N=C/c1c(F)ccc(OC)c1F

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 4/20 0.39
AMY1A P0DUB6 1/20 0.36
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
NFE2L2 Q16236 2/20 0.33
LMNA P02545 2/20 0.33
ALDH1A1 P00352 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
PTGS2 P35354 2/20 0.32
ERN1 O75460 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953115 0.77 MAPT (0.48) LMNAALDH1A1HPGDRAB9ACYP1A2
SCHEMBL23088455 0.77 TUBB1 (0.41) TUBB1HTR2AHTR2CHTR2BNFE2L2
SCHEMBL953686 0.77 ERN1 (0.44) TUBB1LMNAALDH1A1HPGDMAPK1
SCHEMBL953115 0.76 EZH2 (0.36) TUBB1AMY1AHTR2AHTR2CHTR2B
SCHEMBL17221496 0.72 KDM4E (0.56) TUBB1AMY1ANFE2L2LMNAALDH1A1
SCHEMBL17221495 0.72 KDM4E (0.56) TUBB1AMY1ANFE2L2LMNAALDH1A1
SCHEMBL802723 0.71 HTR2A (0.44) TUBB1HTR2AHTR2CHTR2BNFE2L2
SCHEMBL15682035 0.70 CA2 (0.47) TUBB1NFE2L2LMNAALDH1A1KDM4E
SCHEMBL6739214 0.69 KDM4E (0.53) TUBB1AMY1AHTR2AHTR2CHTR2B
SCHEMBL6739211 0.69 KDM4E (0.53) TUBB1AMY1AHTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed